Path Breaking TB Research at JBTDRC & MGIMS
Contact Us






National Symposium on Innovation in TB Diagnostics, Drug Targets and Biomarkers
January 27-28, 2014

JB Tropical Disease Research Centre & Department of Biochemistry
Mahatma Gandhi Institute of Medical Sciences
 Sevagram (Wardha) – 442102, M.S. India

Please Note: Registration Closed. No spot registration is possible due to limitations on space.

Scientific Programme List of Eminent Guest Speakers Status of Receipt of Title, Abstracts etc.

Poster Session Exhibition / Stalls Registration & Accommodation Symposium Brochure Registration Form Important Dates

Tuberculosis remains a major public health threat worldwide. Even though TB was declared as Global emergency by WHO in 1993, multi drug resistance (MDR) and extensive drug resistance (XDR) TB are causing serious concern for health administrators involved in TB Control programmes. One-third of the World’s population is currently infected with tuberculosis bacillus. According to WHO (2009), 9 million new TB cases including 4 million smear positive cases with 15% HIV positivity have been reported causing over 1 million deaths per year. Increase in extrapulmonary tuberculosis is believed to be due to HIV related immune–incompetence. The problems with the current lengthy and complex diagnosis, treatment regimens, lend urgency to the need to develop new methods to diagnose, cure and prevent. In recent times sputum based rapid molecular tests are being reported for faster detection and control in community. However a challenge still remains regarding detection and management of childhood tuberculosis and extrapulmonary tuberculosis in particular affecting pleural, lymph nodes, bone and joints, genitourinary tract and  meninges. Further, without any new anti TB drug for the past 50 years, we have faced an “innovation gap,” and it necessitates that all the research fraternity to meet, collaborate, discuss and share their views for rapid advances in this area. There is urgent need for anti TB drug, a more effective, less toxic and that requires shorter drug regimen for successful TB control programme. New methods of drug susceptibility testing (DST) of shorter duration are being reported which will boost research for new anti TB drugs. Molecular markers have been identified and successfully used as rapid tests for isoniazid and rifampicin resistance. Biomarkers can also help to advance basic knowledge of disease pathogenesis and it's emergence towards resistant variant like extensively drug resistant tuberculosis. With global attention and support, industry is showing considerable interest in TB diagnostics and drug development technologies.
Considering Global and industry’s renewed interest in TB research, this Symposium is planned to review the current advances in molecular and immuno diagnostics, drug targets and biomarkers the important research areas for TB control.  

I.     Keynote addresses, Plenary lectures and Expert Guest talks from India and abroad on the following topics are proposed:

  1. Research priorities for successful management and control of PTB & EPTB at individual & community levels in resource limited countries.
  2. Molecular and immunodiagnostics for Tuberculosis at hospital and community control programmes
  3. HIV-TB coinfection
  4. Childhood Tuberculosis
  5. Non tuberculous mycobacterial infections, a threatening future
  6. Drug resistance and Tuberculosis.
  7. Genomic and proteomic approaches in discovery of TB drug targets & Biomarkers
  8. Mycobacterial proteases – novel drug targets for Tuberculosis
  9. Simple and faster screening techniques for anti TB drugs
  10. In-silico drug design and in-silico screening in anti TB drug development.
  11. Herbal formulations and natural products for improving prognosis and preventing hepatotoxicity during ATT.

Innovation in Molecular and Immunodiagnostics for PTB & EPTB in India
III. Panel Discussion
          Academic and Industrial Cooperation in TB Diagnostics and Drug Development
IV. Poster Sessions

Poster Session

There will be a poster session during 1.00 – 2.30 PM on 27th January. Posters may be on the theme of Symposium and related topics covering Research findings. Three best posters will be selected for Oral Presentation along with letter of appreciation. A space of 3’ X 4’ will be allotted for each poster. (Guidelines for Poster)

Exhibition / Stalls

Exhibition / Stalls for Reagents & Instruments / Technology / Media awareness / Publishers for displaying their products will be arranged at the venue of the event. A space of 10 X 10 ft. will be provided for each stall. As participants are coming from all over India, this is a good scientific forum for companies to display products.  We would appreciate if you could register and also support the Symposium by providing financial assistance of Rs.30,000/- for registration of stall.  The Cheque or DD may please be sent in favour of “National Symposium on TB Diagnostics and Drug Targets” payable at Sevagram / Wardha. Two company representatives will be exempted from payment of Registration fee.
Keeping in mind our long association, which would continue to strengthen, your support would go a long way in the successful organisation of this symposium of great importance.

Registered Stalls

Sr. No. Name of Company No. of stalls booked

Lab Solutions


BD Diagnostics – Diagnostic Systems
Andheri – East, Mumbai


Registration & Accommodation

Registration: The registration fee is payable according to the following schedule:

Conference Delegates

Standard Fee
(Upto 16th Dec. 2013)

Late Surcharge





Rs. 500/-


Accompanying Person

Rs. 600/-


Note:    Advance registration is advised. Registered delegates are entitled for participation at Inaugural and all the Scientific sessions, programme abstract and kit, refreshment, lunch and dinner on both the days.

            For the convenience of all the participants, simple, comfortable and shared accommodation is being arranged in Guest Houses, Yatri Niwas, Athithi Gruh and Gandhi Vichar Parishad near the Institute on payment of Rs.500/- for 3 days for limited number of participants.
Note:  Accommodation will be done on first come first serve basis. Accommodation charges (Rs.500/-) should be enclosed along with Registration Fee.

How to Reach

Reaching Sevagram
Sevagram, the place hallowed by the "Father of Nation" Mahatma Gandhiji, is in Wardha district in the state of Maharashtra, and is located right at the Center of India. It is 80 Km from Nagpur (1.30 Hrs Journey), which is the nearest airport. The district headquarter, Wardha town is 10 Km from Sevagram.
By Rail
Sevagram / Wardha is well connected by trains, as it is at the intersection of Delhi-Chennai, as well as Mumbai-Howrah railway route.
Sevagram station, about 6 Km from MGIMS is located on the Delhi-Chennai trunk route. It has daily train connections with Delhi, Itarsi, Hyderabad, and Chennai. Trains from Lucknow and Patna also halt here.  Wardha Jn.  which is about 10 Km from MGIMS, on the Mumbai-Howrah line. Trains from Mumbai, Ahemadabad, Howrah, and Raipur stop at Wardha junction.
By Road
Direct bus services for Wardha are available from Nagpur, Pune, Amravati, Akola, Latur, Nanded, Aurangabad, Chandrapur and Gadchiroli. Taxis are available at Nagpur Airport as well as both railway stations. Auto-rickshaws run from Sevagram and Wardha stations to MGIMS.
The weather in Sevagram is pleasant, slightly cold at night (Temperature around 12-15oC) light warm clothing is sufficient.

Location Map

Payment Details:
The DD may please be sent in the name of “National Symposium on TB Diagnostics and Drug Targets” payable at Sevagram / Wardha
Details for Electronic transfer:
            A/c. Name.      : National Symposium on TB Diagnostics and Drug Targets
            A/c. No.          : 33103737443
            IFSC Code      : SBIN0012756
            MICR Code    : 442002516
            State Bank of India, Sevagram - 442102

Important Dates:

  • Dates of Symposium   -  January 27-28, 2014
  • Last Date for submission of form (Registration, Accommodation) – 16th December, 2013
  • Submission of Abstract of the paper for Poster  -  16th December, 2013